Background illustration for clinical trials search

Paid Clinical Trials Detroit

Discover 1,725 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of the TheraBionic P1 Device in Breast Cancer

for
Breast Cancer Stage I, Breast Cancer Stage II,
Location: Detroit MI, Farmington Hills MI, Clarkston MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: Female

Age: 22+

Code: NCT07218432

Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Detroit MI, Livonia MI, Farmington Hills MI, Canton MI,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase 3, Recruiting

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Location: Detroit MI, Columbus OH, St Louis MO, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07393282

Phase 3, Recruiting

Horizon Two: HR NDMM (MMRC-100)

for
High Risk Newly Diagnosed Multiple Myeloma
Location: Detroit MI, Chicago IL, St Louis MO, Nashville TN,
Sponsor: Multiple Myeloma Research Consortium

Sex: All

Age: 18+

Code: NCT07053436

Phase 2, Recruiting

A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

for
Non Small Cell Lung Cancer
Location: Detroit MI, Cleveland OH, Pittsburgh PA, Fairfax VA,
Sponsor: Wayshine Biopharm, Inc.

Sex: All

Age: 18+

Code: NCT06868485

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Increasing Knowledge and Interest in Cancer Clinical Trials

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Detroit MI
Sponsor: Hayley Thompson

Sex: All

Age: 21+

Code: NCT06501040

Recruiting

A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

for
Muscle-invasive Bladder Cancer
Location: Detroit MI, Royal Oak MI, Toronto, Chicago IL,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07475806

Phase 2, Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

for
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma,
Location: Detroit MI, Grand Rapids MI, Indianapolis IN,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07488676

Phase 1, Phase 2, Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for
Prostate Cancer (Adenocarcinoma)
Location: Detroit MI, Dearborn MI, Wyandotte MI, Brownstown MI,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase 3, Recruiting

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

for
Cancer, Cancer Survivors, Gastrointestinal Cancers,
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT06908629

Recruiting

First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy

for
Non Small Cell Lung Cancer
Location: Detroit MI
Sponsor: Nerissa T. Viola

Sex: All

Age: 18+

Code: NCT06439914

Phase 1, Recruiting

TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma

for
Hepatocellular Carcinoma Recurrent
Location: Detroit MI, Lapeer MI, Flint MI, Lansing MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 22+

Code: NCT07118202

Recruiting

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Detroit MI, Mount Clemens MI, Farmington Hills MI,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06532279

Phase 2, Recruiting

A Study of ZL-1310 in Participants With Selected Solid Tumors

for
Solid Tumors
Location: Detroit MI, Cleveland OH, Peoria IL, Fairfax VA,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06885281

Phase 1, Phase 2, Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Detroit MI, Hilliard OH, Pittsburgh PA, Toronto,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase 2, Recruiting

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

for
Advanced Solid Tumors, Hematologic Malignancies
Location: Detroit MI, Canton OH, Chicago IL
Sponsor: Acrotech Biopharma Inc.

Sex: All

Age: 18+

Code: NCT07036133

Phase 1, Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

for
AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL),
Location: Detroit MI, Charlottesville VA, New York NY,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 18 - 66

Code: NCT06859424

Phase 2, Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: Detroit MI, Chicago IL, Zion IL, Fairfax VA,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase 1, Recruiting

Dietary Reporting In The Amyloidoses

for
Amyloidosis
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT05738005

Recruiting

A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

for
Carcinoma, Non-Small-Cell Lung
Location: Detroit MI, Canton OH, Milwaukee WI, St Louis MO,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06855771

Phase 2, Recruiting